Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Apyx Medical (APYX) Liabilities from Discontinued Operations (2017)

Apyx Medical filings provide 1 years of Liabilities from Discontinued Operations readings, the most recent being 2248000.0 for Q4 2017.

On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 2248000.0 in Q4 2017 year-over-year; TTM through Dec 2017 was 2248000.0, a N/A change, with the full-year FY2017 number at 2248000.0, changed N/A from a year prior.
Liabilities from Discontinued Operations hit 2248000.0 in Q4 2017 for Apyx Medical.
In the past five years, Liabilities from Discontinued Operations ranged from a high of 2248000.0 in Q4 2017 to a low of 2248000.0 in Q4 2017.